25 May 2013
Keywords: phoqus, move, chronocort, into, ph, ii, london
Article | 09 October 2006
London, UK-based drug delivery company Phoqus says that it will progress Chronocort, a modified-release formulation of hydrocortisone, into
Phase II ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 October 2006
19 February 2007
24 May 2013
© 2013 thepharmaletter.com